Details for Patent: 10,857,212
✉ Email this page to a colleague
Which drugs does patent 10,857,212 protect, and when does it expire?
Patent 10,857,212 protects OPFOLDA and is included in one NDA.
This patent has fifty-one patent family members in thirty countries.
Summary for Patent: 10,857,212
| Title: | Augmented acid alpha-glucosidase for the treatment of Pompe disease |
| Abstract: | A method for treating Pompe disease including administration of recombinant human acid α-glucosidase having optimal glycosylation with mannose-6-phosphate residues in combination with an amount of miglustat effective to maximize tissue uptake of recombinant human acid α-glucosidase while minimizing inhibition of the enzymatic activity of the recombinant human acid α-glucosidase is provided. |
| Inventor(s): | Do Hung V., Khanna Richie, Gotschall Russell |
| Assignee: | Amicus Therapeutics, Inc. |
| Application Number: | US15950347 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 10,857,212
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Therap Us | OPFOLDA | miglustat | CAPSULE;ORAL | 215211-001 | Sep 28, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | THE TREATMENT OF POMPE PATIENTS | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,857,212
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 107277 | ⤷ Try a Trial | |||
| Australia | 2016381832 | ⤷ Try a Trial | |||
| Australia | 2024200071 | ⤷ Try a Trial | |||
| Brazil | 112018013151 | ⤷ Try a Trial | |||
| Canada | 3010205 | ⤷ Try a Trial | |||
| Chile | 2018001773 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
